Sign In
Buy PACB
$1.45
-0.180 (-11.04%)
At Close: Jun 05, 2026
PacBio and Radboud UMC Announce Remarkable Study Results Using HiFi Long Read Sequencing to Help Advance Rare Disease Diagnostics
09:05am, Tuesday, 14'th Jan 2025
MENLO PARK, Calif., Jan. 14, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading provider of highly accurate long-read sequencing solutions, announced a significant publication from Radboud Univ
PacBio Announces Preliminary Fourth Quarter and Full Year Revenue
09:00am, Tuesday, 14'th Jan 2025
Commenced shipment of the Vega ™ benchtop system ahead of schedule, bringing HiFi sequencing to more customers
PacBio Stock May Gain Following the Collaborated Launch of GutID
12:26pm, Monday, 13'th Jan 2025
PACB and Intus Bio collaborate to launch GutID, the first commercial human gut health test.
PACB Stock Rises After the Shipment of Vega Systems to Berry Genomics
09:25am, Friday, 10'th Jan 2025
PacBio delivers the first Vega systems to Berry Genomics to develop and optimize its targeted assays to support screening programs in China and other markets.
PacBio and Intus Bio Collaborate for Launch of GutID, First At-Home Microbiome Test Powered by HiFi Sequencing
06:05am, Friday, 10'th Jan 2025
MENLO PARK, Calif., Jan. 10, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), developer of the world's most advanced sequencing technologies, and Intus Bio, a leader in microbiome research and discover
Why the Market Dipped But Pacific Biosciences of California (PACB) Gained Today
07:36pm, Tuesday, 07'th Jan 2025
Pacific Biosciences of California (PACB) closed at $2 in the latest trading session, marking a +0.5% move from the prior day.
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
11:55am, Tuesday, 07'th Jan 2025
Cathie Wood saw her investments rally in the second half of 2024 after a slow start. The co-founder, CEO, and primary stock picker for Ark Invest is hoping to jump ahead of the market early this year.
PacBio to Present at 43rd Annual J.P. Morgan Healthcare Conference
04:05pm, Thursday, 02'nd Jan 2025
MENLO PARK, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be presenti
Reasons to Retain PacBio Stock in Your Portfolio for Now
01:26pm, Thursday, 12'th Dec 2024
PACB continues to deliver growth from its unique technologies amid business seasonality concerns.
Cathie Wood's Ark Invest Bets Big On Biotech Again As Pacific Biosciences Grabs Spotlight
08:54am, Thursday, 05'th Dec 2024
Ark Invest CEO Cathie Wood is doubling down on genomics.
Pacific Biosciences' Cost Cuts Won't Offset Rising Competition
03:38pm, Tuesday, 12'th Nov 2024
Pacific Biosciences of California stock surged 50% since August despite a 24% YoY revenue decline and deteriorating gross margins due to increased costs and pricing pressures. Q3 revenue of $40 millio
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
11:55am, Tuesday, 12'th Nov 2024
The rock star money manager is starting to roll with the rallying market.
PacBio price target lowered to $6 from $7 at Scotiabank
08:56am, Monday, 11'th Nov 2024
Scotiabank lowered the firm's price target on PacBio to $6 from $7 and keeps an Outperform rating on the shares. The firm lowered its FY24 and FY25 revenue estimates following the company's Q3 update,
PacBio to Present at Upcoming Investor Conferences
04:05pm, Friday, 08'th Nov 2024
MENLO PARK, Calif., Nov. 08, 2024 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be particip
PACB Stock Falls Despite Q3 Earnings Beat, Revenues Decline Y/Y
11:10am, Friday, 08'th Nov 2024
PacBio Q3 2024 revenues decline year over year. However, Consumable, and Service and other revenues increase.
